[Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].

J Bango, P Fadón, F Mata, G Rubio, J Santo-Domingo
{"title":"[Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].","authors":"J Bango,&nbsp;P Fadón,&nbsp;F Mata,&nbsp;G Rubio,&nbsp;J Santo-Domingo","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ecstasy use have raised in recent years and it have been related to psychopathological symptoms. The comsumption pattern associated with psychiatric complications is unknown.</p><p><strong>Method: </strong>Thirty-six case reports about psychiatric complications due to ecstasy and published from 1985 to 1997 were studied.</p><p><strong>Results: </strong>The disorders with higher prevalence were psychosis (n = 21), panic attacks (n = 12) and depressive symptoms (n = 3). Seventy two per cent were substance abusers. Urinary drugs screening were present in 28%, only in two subjects might detect amphetamine. Men had higher MDMA doses compsumption and higher prevalence of background psychiatric disorders than women. Subjects with psychotic symptomatology had more psychiatric background, higher doses of MDMA comsumption and for a long time than individuals with depressive or panic attacks symptomatology.</p><p><strong>Conclusions: </strong>The review of the case reports of psychiatric complications related to ecstasy use do not allow to conclude that ecstasy use was the main responsible factor for psychiatric symptoms. They could be related to an individual vulnerability and or to lasting of comsumption.</p>","PeriodicalId":75429,"journal":{"name":"Actas luso-espanolas de neurologia, psiquiatria y ciencias afines","volume":"26 4","pages":"260-3"},"PeriodicalIF":0.0000,"publicationDate":"1998-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Actas luso-espanolas de neurologia, psiquiatria y ciencias afines","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Ecstasy use have raised in recent years and it have been related to psychopathological symptoms. The comsumption pattern associated with psychiatric complications is unknown.

Method: Thirty-six case reports about psychiatric complications due to ecstasy and published from 1985 to 1997 were studied.

Results: The disorders with higher prevalence were psychosis (n = 21), panic attacks (n = 12) and depressive symptoms (n = 3). Seventy two per cent were substance abusers. Urinary drugs screening were present in 28%, only in two subjects might detect amphetamine. Men had higher MDMA doses compsumption and higher prevalence of background psychiatric disorders than women. Subjects with psychotic symptomatology had more psychiatric background, higher doses of MDMA comsumption and for a long time than individuals with depressive or panic attacks symptomatology.

Conclusions: The review of the case reports of psychiatric complications related to ecstasy use do not allow to conclude that ecstasy use was the main responsible factor for psychiatric symptoms. They could be related to an individual vulnerability and or to lasting of comsumption.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[精神疾病与摇头丸药物(MDMA)的消费:已发表病例报告综述]。
背景:近年来,摇头丸的使用有所增加,并与精神病理症状有关。与精神并发症相关的消费模式尚不清楚。方法:对1985 ~ 1997年发表的36例因摇头丸引起的精神并发症进行回顾性分析。结果:患病率较高的障碍为精神病(21例)、惊恐发作(12例)和抑郁症状(3例),其中药物滥用占72%。有28%的人有尿药筛查,只有两名受试者可能检测到安非他明。男性的MDMA剂量和背景精神疾病患病率均高于女性。具有精神病症状的受试者比具有抑郁或惊恐发作症状的个体有更多的精神病学背景、更高剂量的MDMA消费和较长的时间。结论:通过对与使用摇头丸相关的精神并发症的病例报告的回顾,不能得出使用摇头丸是导致精神症状的主要因素的结论。它们可能与个人的脆弱性和或与消费的持久性有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
[Benzodiazepines in the treatment of schizophrenia: a review]. [Psychiatric symptoms in Cushing syndrome: a clinical case]. [Apolipoproteins and cognitive deterioration]. [Normative data for the neuropsychological evaluation of intravenous drug users]. [Importance of the early diagnosis of malignant neuroleptic syndrome: report of 2 cases].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1